FIELD: pharmacology; medicine.
SUBSTANCE: invention relates to the field of pharmacy and medicine, namely to a method for increasing the level of hemoglobin in the blood in a patient with cancer, in which a pharmaceutical composition containing poloxamer-188 as a pharmacologically active substance is administered before, and/or during, and/or after a course of chemotherapy or immunotherapy.
EFFECT: normalizing and maintaining the general physical condition of the patient at a level that makes it possible to carry out courses of chemotherapy or immunotherapy and improves the general condition of the patient after cancer treatment, while reducing the toxic effects and side effects on the patient’s body.
4 cl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW APPLICATION OF POLOXAMER AS A PHARMACOLOGICALLY ACTIVE SUBSTANCE | 2018 |
|
RU2760324C1 |
| THERMAL METHOD FOR STERILIZATION OF LIQUID MEDICINAL AGENTS CONTAINING POLOXAMER | 2018 |
|
RU2741710C1 |
| PHORBOL ESTER COMPOSITIONS AND METHODS OF USING THEM FOR TREATING OR REDUCING DURATION OF CYTOPENIA | 2015 |
|
RU2730998C2 |
| METHOD OF PREOPERATIVE CORRECTION OF ANEMIA IN PATIENTS WITH COLORECTAL CANCER WITH LIVER METASTASES | 2023 |
|
RU2811959C1 |
| METHOD FOR CORRECTING ANEMIA IN PREOPERATIVE PERIOD IN PATIENTS WITH GASTRIC CANCER | 2020 |
|
RU2759044C1 |
| THERAPEUTIC WAYS FOR TREATING PATIENTS WITH RECOMBINANT ERYTHROPOIETIN OF HIGH ACTIVITY AND DECREASED SIDE EFFECTS | 2001 |
|
RU2282460C2 |
| STIMULATOR OF CYTOKIN AND HEMOPOIETIC FACTORS PRODUCTION AND A METHOD OF ITS USING | 1995 |
|
RU2089179C1 |
| METHOD FOR PREPARING PATIENT FOR AUTOLOGOUS BLOOD TRANSFUSION IN VAST SURGERY OPERATIONS | 2002 |
|
RU2227044C2 |
| AGENT FOR REGULATION OF ENDOGENOUS PRODUCTION OF CYTOKINE AND HEMOPOIETIC FACTOR (VARIANTS) AND METHOD OF ITS USING | 1996 |
|
RU2153351C2 |
| METHOD FOR PREVENTING AND CORRECTING ANEMIA STATE IN METASTATIC MAMMARY GLAND CARCINOMA PATIENTS | 2005 |
|
RU2314122C2 |
